• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: APOLLO ENDOSURGERY, INC. OVERTUBE ENDOSCOPIC ACCESS SYSTEM; ENDOSCOPIC ACCESS OVERTUBE, GASTROENTEROLOGY-UROLOGY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

APOLLO ENDOSURGERY, INC. OVERTUBE ENDOSCOPIC ACCESS SYSTEM; ENDOSCOPIC ACCESS OVERTUBE, GASTROENTEROLOGY-UROLOGY Back to Search Results
Model Number OVT-027-160
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Pneumothorax (2012); Perforation of Esophagus (2399)
Event Date 03/31/2021
Event Type  Injury  
Event Description
Narrative from staff: the case was booked as an endoscopic revision of gastric bypass.Apollo endo-surgery products were used along with a gastroscope 190 model.A gastroscope 180 was used prior to the 190 scope as a diagnostic scope.After the gastroscope 190 was inserted along with the apollo endoscopic suturing system and the overtube access system, it was discovered that there was an esophageal perforation.It is unknown what the cause of the perforation was.A second surgeon was called to assist with the perforation, and endoscopic clips were placed.During the procedure the patient¿s stats deteriorated, and a code was called.Compressions were given to the patient.It was determined that patient had a tension pneumothorax which was decompressed with a 14g angiocatheter.Chest tubes were then placed bilaterally.The patient¿s stats were then stabilized.Narrative from operative report: surgeon started by cauterizing a dilated anastomosis in a horseshoe type fashion with a biopsy forceps covering approximately 2/3 of the inferior anastomosis.Cautery in this location allows improved plication durability.After 270-degree cauterization of the dilated anastomosis the gastroscope was removed and a well lubricated therapeutic scope inserted transorally into the over tube under direct visualization.This scope had the over stitch device in place which was tested on the back table before insertion.During the insertion of the device an esophageal perforation was noted just distal to the overtube.The device was immediately removed.Manufacturer response for endoscopic access overtube, gastroenterology-urology, overtube endoscopic access system (per site reporter): unsure of response of representative that was in the or during the procedure.Manufacturer response for overstitch sx endoscopic suturing system, (brand not provided) (per site reporter): unsure of response of representative that was in the or during the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OVERTUBE ENDOSCOPIC ACCESS SYSTEM
Type of Device
ENDOSCOPIC ACCESS OVERTUBE, GASTROENTEROLOGY-UROLOGY
Manufacturer (Section D)
APOLLO ENDOSURGERY, INC.
1120 s capital of tx hwy
bldg 1, ste 300
austin TX 78746
MDR Report Key11619016
MDR Text Key243973701
Report Number11619016
Device Sequence Number1
Product Code FED
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 04/01/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/06/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberOVT-027-160
Device Catalogue NumberOVT-027-160
Device Lot Number2010-2043
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Report Sent to FDA04/01/2021
Event Location Hospital
Date Report to Manufacturer04/06/2021
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age26645 DA
Patient Weight88
-
-